home All News open_in_new Full Article
Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug
today 1 week ago attach_file Economics
attach_file
Politics
attach_file
Society
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Events
attach_file
Events
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
ID: 2206928764